Impact of 2023 Updated IDSA Guidelines on Antimicrobial Resistant Gram-Negative Infection Treatment


Dr Christian Sandrock evaluates the impact of 2023 updated IDSA guidelines on treatment decisions for patients with antimicrobial resistant gram-negative infections and for patients with multidrug-resistant pathogens.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.